Počet záznamov: 1
Dihydroergotamine and ergotamine: pharmacological differences and therapeutic role in migraine
SYS c018764 LBL ^^^^^nam^^22^^^^^^^^450^ 005 20010517141523.0 100 $a 19970327d1997 u y0sloc0103 ba 101 0-
$a eng 102 $a US 105 $a y z 100yy 200 1-
$a Dihydroergotamine and ergotamine: pharmacological differences and therapeutic role in migraine $e <a> workshop held at the fall symposium of the American Association for the Study of Headache, Sonesta Beach, Bermuda, October 13, 1994 $f edit. Stephen D. Silberstein 210 $a Illinois $c American Association for the Study of Headache $d 1997 215 $a 45 s. 225 2-
$a Headache $v Suppl. 1 541 1-
$a Dihydroergotamín a ergotamín: farmakologické rozdiely a terapeutická úloha pri migréne $z slo 606 $3 sllk_un_auth*d008881 $a migréna $x diagnostika $x farmakoterapia $2 mesh 606 $a ergotamíny $x farmakológia $2 mesh $3 sllk_un_auth*d004879 606 $a ergotamín $x farmakológia $x farmakokinetika $2 mesh $3 sllk_un_auth*d004878 606 $a dihydroergotamín $x farmakológia $x farmakokinetika $2 mesh $3 sllk_un_auth*d004087 606 $a bolesť hlavy, klastrová $x farmakoterapia $2 mesh $3 sllk_un_auth*d003027 606 $3 sllk_un_auth*d003226 $a kongresy ako téma $y Spojené štáty americké $y Bermudské ostrovy $2 mesh 606 $a ergotamín $2 mesh $3 sllk_un_auth*d004878 606 $a dihydroergotamín $2 mesh $3 sllk_un_auth*d004087 675 $a 616.857-085:615.225.1(061.3) $v 1. stred. $z slo 702 -1
$a Silberstein $b Stephen D. $3 sllk_un_auth*p0004863 $4 340 801 -0
$a SK $b BA006 $c 19981223 $g AACR2
Počet záznamov: 1